Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Shan Chuan Zhao"'
Autor:
Julie A. Shields, Samuel R. Meier, Madhavi Bandi, Erin E. Mulkearns-Hubert, Nicole Hajdari, Maria Dam Ferdinez, Justin L. Engel, Daniel J. Silver, Binzhang Shen, Wenhai Zhang, Christopher G. Hubert, Kelly Mitchell, Sajina Shakya, Shan-Chuan Zhao, Alborz Bejnood, Minjie Zhang, Robert Tjin Tham Sjin, Erik Wilker, Justin D. Lathia, Jannik N. Andersen, Yingnan Chen, Fang Li, Barbara Weber, Alan Huang, Natasha Emmanuel
Publikováno v:
Cancer Research. 82:4044-4057
Synthetic lethality is a genetic interaction that results in cell death when two genetic deficiencies co-occur but not when either deficiency occurs alone, which can be co-opted for cancer therapeutics. Pairs of paralog genes are among the most strai
Autor:
Natasha Emmanuel, Alan Huang, Barbara Weber, Fang Li, Yingnan Chen, Jannik N. Andersen, Justin D. Lathia, Erik Wilker, Robert Tjin Tham Sjin, Minjie Zhang, Alborz Bejnood, Shan-Chuan Zhao, Sajina Shakya, Kelly Mitchell, Christopher G. Hubert, Wenhai Zhang, Binzhang Shen, Daniel J. Silver, Justin L. Engel, Maria Dam Ferdinez, Nicole Hajdari, Erin E. Mulkearns-Hubert, Madhavi Bandi, Samuel R. Meier, Julie A. Shields
Supplementary Data from VRK1 Is a Synthetic–Lethal Target in VRK2-Deficient Glioblastoma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0d7811beccd133c06046eb1740fd29b4
https://doi.org/10.1158/0008-5472.22432943.v1
https://doi.org/10.1158/0008-5472.22432943.v1
Autor:
Natasha Emmanuel, Alan Huang, Barbara Weber, Fang Li, Yingnan Chen, Jannik N. Andersen, Justin D. Lathia, Erik Wilker, Robert Tjin Tham Sjin, Minjie Zhang, Alborz Bejnood, Shan-Chuan Zhao, Sajina Shakya, Kelly Mitchell, Christopher G. Hubert, Wenhai Zhang, Binzhang Shen, Daniel J. Silver, Justin L. Engel, Maria Dam Ferdinez, Nicole Hajdari, Erin E. Mulkearns-Hubert, Madhavi Bandi, Samuel R. Meier, Julie A. Shields
Supplementary Figure from VRK1 Is a Synthetic–Lethal Target in VRK2-Deficient Glioblastoma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1d7c73848cbb0737ae2cb91f5db8123b
https://doi.org/10.1158/0008-5472.22432931
https://doi.org/10.1158/0008-5472.22432931
Autor:
Natasha Emmanuel, Alan Huang, Barbara Weber, Fang Li, Yingnan Chen, Jannik N. Andersen, Justin D. Lathia, Erik Wilker, Robert Tjin Tham Sjin, Minjie Zhang, Alborz Bejnood, Shan-Chuan Zhao, Sajina Shakya, Kelly Mitchell, Christopher G. Hubert, Wenhai Zhang, Binzhang Shen, Daniel J. Silver, Justin L. Engel, Maria Dam Ferdinez, Nicole Hajdari, Erin E. Mulkearns-Hubert, Madhavi Bandi, Samuel R. Meier, Julie A. Shields
Synthetic lethality is a genetic interaction that results in cell death when two genetic deficiencies co-occur but not when either deficiency occurs alone, which can be co-opted for cancer therapeutics. Pairs of paralog genes are among the most strai
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9f921d7451ee0ff84f802ca033cb2b50
https://doi.org/10.1158/0008-5472.c.6514274.v1
https://doi.org/10.1158/0008-5472.c.6514274.v1
Autor:
Julie Shields, Samuel Meier, Madhavi Bandi, Maria Dam Ferdinez, Justin Engel, Erin Mulkearns-Hubert, Nicole Hajdari, Binzhang Shen, Christopher Hubert, Kelly Mitchell, Wenhai Zhang, Shan-chuan Zhao, Alborz Bejnood, Minjie Zhang, Robert Tjin Tham Sjin, Erik Wilker, Justin Lathia, Jannik Andersen, Yingnan Chen, Fang Li, Barbara Weber, Alan Huang, Natasha Emmanuel
Publikováno v:
Neuro-Oncology. 24:vii29-vii30
Synthetic lethality — a genetic interaction that results in cell death when two genetic deficiencies co-occur but not when either deficiency occurs alone — can be co-opted for cancer therapeutics. A pair of paralog genes is among the most straigh
Autor:
Julie A. Shields, Samuel R. Meier, Madhavi Bandi, Maria Dam Ferdinez, Justin L. Engel, Erin E. Mulkearns-Hubert, Nicole Hajdari, Kelly Mitchell, Wenhai Zhang, Shan-chuan Zhao, Minjie Zhang, Robert Tjin Tham Sjin, Erik Wilker, Justin D. Lathia, Jannik N. Andersen, Yingnan Chen, Fang Li, Barbara Weber, Alan Huang, Natasha Emmanuel
Synthetic lethality — a genetic interaction that results in cell death when two genetic deficiencies co-occur but not when either deficiency occurs alone — can be co-opted for cancer therapeutics. A pair of paralog genes is among the most straigh
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d3dfbb58d5fb311a79e246324a8f59df
https://doi.org/10.1101/2021.12.30.474571
https://doi.org/10.1101/2021.12.30.474571
Autor:
Teng Teng, Stephen Paik, Shan-chuan Zhao, Ashley Choi, Steven A. Lombardo, Shangtao Liu, Samuel R. Meier, Yi Yu, Jannik N. Anderson, Alan Huang, Fang Li, Xuewen Pan
Publikováno v:
Molecular Cancer Therapeutics. 20:P095-P095
TP53 is the most mutated tumor suppressor gene in human cancers and is a master regulator of a wide array of cellular processes including but not limited to cell cycle progression and DNA damage response. Due to its diverse functions, therapies speci
Autor:
Julie Shields, Samuel R. Meier, Justin Engel, Madhavi Bandi, Maria L. Dam Ferdinez, Wenhai Zhang, Shan-chuan Zhao, Minjie Zhang, Ashley Choi, Yi Yu, Xuewen Pan, Brian McMillan, Brett Williams, Robert Tjin Tham Sjin, Douglas Whittington, Erik Wilker, Alan Huang, Fang Li, Natasha Emmanuel
Publikováno v:
Molecular Cancer Therapeutics. 20:P182-P182
Synthetic lethality — the genetic interaction that causes cell death when two genetic deficiencies co-occur but cell survival when each deficiency occurs alone — can be co-opted for cancer therapeutics. A pair of paralog genes is among the most s
Autor:
Silvia Fenoglio, Aileen M. Cristo, James Tepper, Teng Teng, Samuel R. Meier, Ashley Choi, Hongxiang Zhang, Shan-chuan Zhao, Shangtao Liu, Leanne G. Ahronian, Daniel Aird, Nikitha M. Das, Yi Yu, Robert Tjin Tham Sjin, Jannik N. Andersen, Alan Huang, Fang Li, Xuewen Pan
Publikováno v:
Molecular Cancer Therapeutics. 20:P183-P183
KRAS is the most frequently mutated oncogene in human tumors and drives tumorigenesis across multiple lineages. Specifically, KRAS is mutated in about 30% of lung cancer and over 90% of pancreatic cancer. Despite recent progress in developing mutant
Autor:
Teresa Compton, Leah J. Anderson, Gejing Deng, Kai Lin, Shan Chuan Zhao, Kara Balabanis, Brigitte Wiedmann, Chad Vickers, Roger Aki Fujimoto, Christina Rau, Lac Lee, Gerard Joberty, Jason Borawski, Markus Schirle, Piroska Dévay, Jeremy Baryza, Tewis Bouwmeester, Craig Mickanin, L. Alex Gaither
Publikováno v:
Virology. 397(1):43-55
Three cyclophilin inhibitors (DEBIO-025, SCY635, and NIM811) are currently in clinical trials for hepatitis C therapy. The mechanism of action of these, however, is not completely understood. There are at least 16 cyclophilins expressed in human cell